Inseon Song

Title: Inseon Song: Innovator in Epilepsy Research

Introduction

Inseon Song is a notable inventor based in Gunpo, South Korea. He has made significant contributions to the field of neuroscience, particularly in the study of epilepsy. His innovative work has led to the development of a unique transgenic mouse model that aids in understanding the mechanisms of epilepsy.

Latest Patents

Inseon Song holds a patent for a transgenic mouse whose genome comprises a homozygous disruption of its α1G gene. This patent describes a method for resistance to epilepsy by suppressing the function of the alpha 1G protein of T-type calcium channels. The invention includes knockout mice that resist epilepsy by disrupting the alpha 1G subunit of the T-type calcium channel. This model can be utilized for investigating the relationship between various diseases, particularly neuropathy or psychopathy, and the function of the α1G T-type calcium channel through various behavioral tests. The α1G-knockout transgenic mouse is also valuable for screening antiepileptic agents.

Career Highlights

Inseon Song is currently associated with Orient Bio, Inc., where he continues to advance his research in the field of epilepsy. His work has garnered attention for its potential applications in developing new treatments for epilepsy and related disorders.

Collaborations

Inseon collaborates with notable colleagues, including Hee-Sup Shin and Daesoo Kim. Their combined expertise contributes to the innovative research being conducted at Orient Bio, Inc.

Conclusion

Inseon Song's contributions to epilepsy research through his innovative transgenic mouse model highlight the importance of scientific advancements in understanding and treating neurological disorders. His work continues to pave the way for future discoveries in the field.